Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer

Diletta Di Mitri1, Andrea Alimonti2

  • 1Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, Bellinzona 6500, Switzerland.

Trends in Cell Biology
|November 14, 2015
PubMed

Insights

Cellular senescence, a key tumor barrier, is regulated by both cell-intrinsic factors and the tumor microenvironment. New findings highlight the crucial role of non-cell-autonomous mechanisms in senescence initiation and cancer progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Cellular senescence acts as a critical barrier against cancer initiation and progression.
  • Senescence is prevalent in premalignant lesions, and escape from this state is necessary for tumor advancement.
  • While cell-autonomous factors influence senescence, the tumor microenvironment's role is increasingly recognized.

Purpose of the Study:

  • To review the emerging evidence on the regulation of cellular senescence within the tumor microenvironment.
  • To discuss the non-cell-autonomous mechanisms that control senescence initiation in cancer.

Main Methods:

  • Literature review of recent findings on cellular senescence and cancer.
  • Analysis of studies investigating the tumor microenvironment's impact on senescence.
  • Synthesis of evidence regarding cytokines and immune cells in senescence regulation.

Main Results:

  • Cellular senescence is a significant anti-tumorigenic mechanism.
  • Tumor progression often involves overcoming senescence.
  • Both cell-autonomous (genetic alterations, targeted therapies) and non-cell-autonomous (tumor microenvironment) mechanisms regulate senescence.

Conclusions:

  • The tumor microenvironment plays a fundamental role in regulating cellular senescence.
  • Cytokines and tumor-infiltrating immune cells modulate the senescence response.
  • Senescence initiation relies on both cell-intrinsic and extrinsic (non-cell-autonomous) factors, underscoring the complexity of cancer biology.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K